Last update:

Oncology & Cancer news

Oncology & Cancer

US lung cancer screening fails most patients, according to study

In a study of nearly 1,000 consecutive patients treated for lung cancer at Northwestern Medicine, researchers discovered only 35% would have qualified for screening, according to the U.S. Preventive Services Task Force (USPSTF) ...

Oncology & Cancer

Genetic events that can trigger leukemia in patients with a rare disorder deciphered

Two parallel and complementary studies conducted by the IDIBELL team led by Dr. Alessandra Giorgetti have succeeded in recreating models of GATA2 deficiency disease, a rare genetic disorder that affects fewer than 1 million ...

Oncology & Cancer

Diagnostics for pancreatic cancer can improve with the help of AI

Pancreatic cancer is the deadliest form of cancer worldwide, mainly because the disease is often discovered late. Symptoms associated with these tumors are often non-specific, so patients and doctors do not immediately suspect ...

Oncology & Cancer

A microRNA cocktail weakens brain tumors in preclinical trials

A patented RNA-based cocktail developed at the Italian Institute of Technology (IIT-Istituto Italiano di Tecnologia) has emerged as a promising active agent against tumors of the central nervous system, such as glioblastoma.

Oncology & Cancer

Chronic hepatitis C linked to increased risk of pancreatic cancer

A new study from Yale School of Medicine researchers has found a positive link between chronic hepatitis C and pancreatic cancer. The study, which was published in JAMA Network Open, revealed that individuals with chronic ...

Medical research

French scientists probe mRNA's potential to fight cancer

Inside a lab in the French city of Orleans, scientists are testing out the limits of molecules in our body called messenger RNA—best known for being used in COVID-19 vaccines—in the hopes of finding a breakthrough treatment ...

Oncology & Cancer

Cancer uses cell death proteins to survive treatment and regrow

The emergence of cancer drug resistance remains one of the most pressing problems in cancer care and there is a critical need to devise approaches to mitigate it. However, the molecular mechanisms driving treatment resistance ...

Medications

Targeted drug could benefit young patients with invasive sarcoma

A collaborative research team, led by scientists at VCU Massey Comprehensive Cancer Center and Huntsman Cancer Institute at the University of Utah, has identified a targeted drug that could effectively treat an aggressive ...